
Current issue
Archive
About the journal
Editorial board
Reviewers
Abstracting and indexing
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
4/2024
vol. 9 abstract:
Original paper
A new aberration in the VPS33B gene - a description of the familial occurrence of ARCS1 syndrome
Olga Adamczyk-Gruszka
1
,
Mariola Głowacka
2
,
Jakub Gruszka
3
,
Maciej Kłosowski
4
,
Anna Zwierzyńska
5
Long-Term Care Nursing 2024; 9 (4): 14-20
Online publish date: 2025/01/04
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
ARCS1 -arthrogryposis is an autosomal recessive multisystem disorder. The disease affects the liver, kidneys, skin, central nervous system, musculoskeletal system. It is the result of mutations in the genes VPS33B (Vacuolar protein sorting 33 homolog B) on chromosome 15q26.1 - 75% of cases) and VIPAR (VPS33B interacting protein, apical-basolateral polarity regulator - 25% of cases). Prevalence is not exactly known. About 100 cases have been described so far. The syndrome has no curative therapy and the prognosis is poor. Patients usually die before 7 months of age due to recurrent infections, severe dehydration, metabolic acidosis, or internal hemorrhage.
keywords:
ARCS1, arthrogryposis, renal dysfunction syndrome, cholestasis, VPS33B protein |